(Q31066946)

28 June 2017

Medication compliance and disease exacerbation in patients with asthma: a retrospective study of managed care data (English)

1 reference

28 June 2017

1 reference

Lee Stern

1

1 reference

28 June 2017

Jeff Berman

2

1 reference

28 June 2017

William Lumry

3

1 reference

28 June 2017

Laura Katz

4

1 reference

28 June 2017

Lujing Wang

5

1 reference

28 June 2017

Lisa Rosenblatt

6

1 reference

28 June 2017

John J Doyle

7

1 reference

28 June 2017

1 September 2006

1 reference

Annals of Allergy, Asthma & Immunology

28 June 2017

1 reference

28 June 2017

97

1 reference

28 June 2017

3

1 reference

28 June 2017

402-408

1 reference

Using a matrix as an educational approach to asthma

28 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960808-3

7 January 2021

Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960808-3

7 January 2021

Medication compliance and asthma: overlooking the trees because of the forest

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960808-3

7 January 2021

Risk factors for childhood asthma and wheezing. Importance of maternal and household smoking

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960808-3

7 January 2021

Asthma economics: focusing on therapies that improve costly outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960808-3

7 January 2021

Is asthma self-management cost-effective?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960808-3

7 January 2021

Evaluation of different inhaled combination therapies (EDICT): a randomised, double-blind comparison of Seretide (50/250 microg bd Diskus vs. formoterol (12 microg bd) and budesonide (800 microg bd) given concurrently (both via Turbuhaler) in patien

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960808-3

7 January 2021

Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960808-3

7 January 2021

Reduction in patient timing errors using a breath-activated metered dose inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960808-3

7 January 2021

Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960808-3

7 January 2021

10.1016/S1081-1206(10)60808-3

Identifiers

DOI

1 reference

28 June 2017

1 reference